Skip to main content
Clinical Trials/CTRI/2024/05/067056
CTRI/2024/05/067056
Not yet recruiting
Phase 4

Influenza Vaccine to reduce cardiovascular events in patients with recent myocardial infarction: a multicentric randomized, double-blind palcebo-controlled trial. - NI

Indian Council of Medical Research, India0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: I219- Acute myocardial infarction, unspecified
Sponsor
Indian Council of Medical Research, India
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Indian Council of Medical Research, India

Eligibility Criteria

Inclusion Criteria

  • Patients \> 45 year old with physician diagnosed MI (ST elevation and non ST elevation) in the previous 12 weeks consenting to participate will be randomized to intervention or control arm

Exclusion Criteria

  • 1\) Anaphylactic reaction to a previous dose of influenza vaccine,
  • 2\) IgE\-mediated hypersensitivity to egg protein manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock;
  • 3\) Guillain\-Barré syndrome within eight weeks of a previous influenza vaccine;
  • 4\) Anaphylactic reaction to neomycin
  • 5\) Influenza vaccine in the previous one year;
  • 6\) Plan to be vaccinated with flu vaccine in coming year

Outcomes

Primary Outcomes

Not specified

Similar Trials